Skip to main content

Table 1 Demographics and genetic testing results

From: Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program

Criteria

 

Number (%)

Gender

Male

32 (31.4)

Female

70 (68.6)

Ethnicity

White/Caucasian (non-Jewish)

89 (87.3)

White/Caucasian (Jewish)

12 (11.8)

Asian

1 (1.0)

Age

 

Mean (Range)

Overall

56 (35-78y)

Male

57 (37-78y)

Female

56 (35-72y)

Family history

1 FDR (plus 1 or more SDR)

38 (37.3)

2 FDR (+/− 1 or more SDR)

30 (29.4)

3 FDR (+/− 1 or more SDR)

11 (10.8)

BRCA2 (plus 1 or more relative with PC)

22 (21.6)

Clinical diagnosis of PJS

1 (1.0)

Genetic testing and previous malignancy

Not tested

Total

31 (30.4)

(including PJS participant)

None

30 (29.4)

Breast

1 (1.0)

No mutation identified

Total

49 (48.0)

(Self or close affected relative)

Nil cancer

42 (41.2)

Thyroid

1 (1.0)

Breast

5 (4.9)

Melanoma

1 (1.0)

BRCA2 carrier

Total

22 (21.6)

 

Nil cancer

10 (9.8)

Breast

5 (4.9)

Breast – Bilateral

4 (3.9)

Prostate

1 (1.0)

Prostate/Brain tumour

1 (1.0)

Melanoma

1 (1.0)

Smoking statusa

Never smoked

56 (55.4)

Previous smoker

41 (40.6)

Current smoker

4 (4.0)

Alcohol consumptionb

Non-drinker

17 (17.0)

Social drinker

19 (19.0)

Weekly drinker

36 (36.0)

Daily drinker

28 (28.0)

  1. a one data point not declared; b two data points not declared